U.S. Pharmaceutical Market (2025 - 2030) Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts

Table of Contents

Chapter 1. U.S. Pharmaceutical Market: Methodology and Scope
                   1.1. Market Segmentation and Scope
                        1.1.1. Segment Definitions
                   1.2. Estimates and Forecast Timeline
                   1.3. Objectives
                        1.3.1. Objective - 1
                        1.3.2. Objective - 2
                        1.3.3. Objective - 3
                   1.4. Research Methodology
                   1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                   1.6. Information or Data Analysis
                        1.6.1. Data Analysis Models
                   1.7. Market Formulation & Validation
                   1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                   1.9. List of Secondary Sources
                   1.10. List of Abbreviations
Chapter 2. U.S. Pharmaceutical Market: Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Pharmaceutical Market Variables, Trends, & Scope
                   3.1. Market Segmentation and Scope
                   3.2. Market Dynamics
                        3.2.1. Market Drivers Analysis
                             3.2.1.1. Increasing healthcare spending by the government
                             3.2.1.2. Improving affordability driven by rising per capita income
                             3.2.1.3. Increasing awareness about healthcare among the population
                             3.2.1.4. Increasing access to innovative and modern medicines
                             3.2.1.5. Demographic and lifestyle changes leading to rising prevalence of chronic diseases
                             3.2.1.6. Rising chronic diseases and geriatric population
                        3.2.2. Market Restraint Analysis
                             3.2.2.1. COVID-19 pandemic
                             3.2.2.2. Intensification of competition from generic and biosimilar drugs
                             3.2.2.3. Increasing price-sensitivity of customers for non-reimbursed drugs
                             3.2.2.4. Increasing barriers to market access and decreasing R&D productivity of pharma companies
                   3.3. Porter’s Five Forces Analysis
                   3.4. PESTLE Analysis

Chapter 4. U.S. Pharmaceutical Market: Molecule Type Outlook Estimates & Trend Analysis
                   4.1. Molecule Type Outlook: Movement Analysis
                   4.2. Biologics & Biosimilars (Large Molecules)
                        4.2.1. Biologics & Biosimilars Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                             4.2.1.1 Biologics & Biosimilars (Large Molecules)
                             4.2.1.2 Biologics & Biosimilars Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                                  4.2.1.2.1 Monoclonal Antibodies
                                  4.2.1.2.2 Monoclonal Antibodies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                             4.2.3.1 Vaccines
                             4.2.3.2 Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                                  4.2.3.1.1 Cell & Gene Therapy
                                  4.2.3.3.2 Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                             4.2.5.1 Others
                             4.2.5.2 Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                   4.3. Conventional Drugs (Small Molecules)
                        4.3.1. Conventional Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. U.S. Pharmaceutical Market: Product Estimates & Trend Analysis
                   5.1. U.S. Pharmaceutical Market: Product Movement Analysis
                   5.2. Branded
                        5.2.1. Branded Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   5.3. Generic
                        5.3.1. Generic Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. U.S. Pharmaceutical Market: Type Estimates & Trend Analysis
                   6.1. U.S. Pharmaceutical Market: Type Movement Analysis
                   6.2. Prescription
                        6.2.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   6.3. OTC
                        6.3.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. U.S. Pharmaceutical Market: Disease Outlook Estimates & Trend Analysis
                   7.1. U.S. Pharmaceutical Market: Disease Outlook Movement Analysis
                   7.2. Cardiovascular diseases
                        7.2.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.3. Cancer
                        7.3.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.4. Diabetes
                        7.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.5. Infectious diseases
                        7.5.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.6. Neurological disorders
                        7.6.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.7. Respiratory diseases
                        7.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.8. Autoimmune diseases
                        7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.9. Mental health disorders
                        7.9.1. Mental Health Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.10. Gastrointestinal disorders
                        7.10.1. Gastrointestinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.11. Women’s Health Diseases
                        7.11.1. Women’s Health Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.12. Genetic and Rare genetic diseases
                        7.12.1. Genetic and Rare Genetic Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.13. Dermatological conditions
                        7.13.1. Dermatological Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.14. Obesity
                        7.14.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.15. Renal diseases
                        7.15.1. Renal Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.16. Liver conditions
                        7.16.1. Liver Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.17. Hematological disorders
                        7.17.1. Hematological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.18. Eye conditions
                        7.18.1. Eye Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.19. Infertility conditions
                        7.19.1. Infertility Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.20. Endocrine disorders
                        7.20.1. Endocrine Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.21. Allergies
                        7.21.1. Allergies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   7.22. Others
                        7.22.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. U.S. Pharmaceutical Market: Route of Administration Estimates & Trend Analysis
                   8.1. U.S. Pharmaceutical Market: Route of Administration Movement Analysis
                   8.2. Oral
                        8.2.1. Oral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   8.3. Topical
                        8.3.1. Topical Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   8.4. Parenteral
                        8.4.1. Parenteral Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                             8.4.1.1. Intravenous
                             8.4.1.2. Intramuscular
                   8.5. Inhalations
                        8.5.1. Inhalations Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   8.6. Other
                        8.6.1. Other Route Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 9. U.S. Pharmaceutical Market: Age Group Estimates & Trend Analysis
                   9.1. U.S. Pharmaceutical Market: Age Group Movement Analysis
                   9.2. Children & Adolescents
                        9.2.1. Children & Adolescents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   9.3. Adults
                        9.3.1. Adults Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   9.4. Geriatric
                        9.4.1. Geriatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 10. U.S. Pharmaceutical Market: Distribution Channel Group Estimates & Trend Analysis
                   10.1. U.S. Pharmaceutical Market: Distribution Channel Group Movement Analysis
                   10.2. Hospital Pharmacy
                        10.2.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   10.3. Retail Pharmacy
                        10.3.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                   10.4. Others
                        10.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 11. Competitive Landscape
                   11.1. Company Categorization
                   11.2. Strategy Mapping
                        11.2.1. NEW PRODUCT LAUNCH
                        11.2.2. PARTNERSHIPS
                        11.2.3. ACQUISITION
                        11.2.4. COLLABORATION
                        11.2.5. FUNDING
                   11.3. Key Company Market Share Analysis, 2024
                   11.4. Company Heat Map Analysis
                   11.5. Company Profiles
                        11.5.1. F. HOFFMANN-LA ROCHE LTD
                             11.5.1.1. Company Overview
                             11.5.1.2. Financial Performance
                             11.5.1.3. Product Benchmarking
                             11.5.1.4. Strategic Initiatives
                        11.5.2. NOVARTIS AG
                             11.5.2.1. Company Overview
                             11.5.2.2. Financial Performance
                             11.5.2.3. Product Benchmarking
                             11.5.2.4. Strategic Initiatives
                        11.5.3. ABBVIE INC.
                             11.5.3.1. Company Overview
                             11.5.3.2. Financial Performance
                             11.5.3.3. Product Benchmarking
                             11.5.3.4. Strategic Initiatives
                        11.5.4. JOHNSON & JOHNSON SERVICES, INC.
                             11.5.4.1. Company Overview
                             11.5.4.2. Financial Performance
                             11.5.4.3. Product Benchmarking
                             11.5.4.4 Strategic Initiatives
                        11.5.5. MERCK & CO., INC.
                             11.5.5.1. Company Overview
                             11.5.5.2. Financial Performance
                             11.5.5.3. Product Benchmarking
                             11.5.5.4. Strategic Initiatives
                        11.5.6. PFIZER INC.
                             11.5.6.1. Company Overview
                             11.5.6.2. Financial Performance
                             11.5.6.3. Product Benchmarking
                             11.5.6.4. Strategic Initiatives
                        11.5.7. BRISTOL-MYERS SQUIBB COMPANY
                             11.5.7.1. Company Overview
                             11.5.7.2. Financial Performance
                             11.5.7.3. Product Benchmarking
                             11.5.7.4. Strategic Initiatives
                        11.5.8. SANOFI
                             11.5.8.1. Company Overview
                             11.5.8.2. Financial Performance
                             11.5.8.3. Product Benchmarking
                             11.5.8.4. Strategic Initiatives
                        11.5.9. GSK PLC.,
                             11.5.9.1. Company Overview
                             11.5.9.2. Financial Performance
                             11.5.9.3. Product Benchmarking
                             11.5.9.4. Strategic Initiatives
                        11.5.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
                             11.5.10.1. Company Overview
                             11.5.10.2. Financial Performance
                             11.5.10.3. Product Benchmarking
                             11.5.10.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 4 U.S. Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 5 U.S. Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 6 U.S. Pharmaceutical Market, By Disease, 2018 - 2030 (USD Billion)
Table 7 U.S. Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 8 U.S. Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 9 U.S. Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 U.S. Pharmaceutical Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 U.S. Pharmaceutical Market: Product outlook and key takeaways
FIG. 15 U.S. Pharmaceutical Market: Product movement analysis & market share 2024 & 2030
FIG. 16 Branded U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 17 Generics U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 18 U.S. Pharmaceutical Market: Type outlook and key takeaways
FIG. 19 U.S. Pharmaceutical Market: Type movement analysis & market share 2024 & 2030
FIG. 20 Prescription U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 21 OTC U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 22 U.S. Pharmaceutical Market: Therapeutic category outlook and key takeaways
FIG. 23 U.S. Pharmaceutical Market: Therapeutic category movement analysis & market share 2024 & 2030
FIG. 24 Oncology U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 25 Anti-infectives U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 26 Cardiovascular diseases U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 27 CNS disorders U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 28 Metabolic disorders U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 29 GI disorders U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 30 Respiratory diseases U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 31 Others U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 32 U.S. Pharmaceutical Market: Formulation outlook and key takeaways
FIG. 33 U.S. Pharmaceutical Market: Formulation movement analysis & market share 2024 & 2030
FIG. 34 Tablets U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 35 Capsules U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 36 Injectables U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 37 Sprays U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 38 Suspensions U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 39 Powders U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 40 Others formulation U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 41 U.S. Pharmaceutical Market: Age group outlook and key takeaways
FIG. 42 U.S. Pharmaceutical Market: Age group movement analysis & market share 2024 & 2030
FIG. 43 Children & Adolescents U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 44 Adults U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)
FIG. 45 Geriatric U.S. Pharmaceutical Market, 2018 - 2030 (USD Billion)